J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Joinn Laboratories China Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Capital Expenditures
-ÂĄ218.7m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Capital Expenditures
-ÂĄ4.6B
CAGR 3-Years
0%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Capital Expenditures
-ÂĄ2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Capital Expenditures
-ÂĄ3.5B
CAGR 3-Years
21%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Capital Expenditures
-ÂĄ378.9m
CAGR 3-Years
-11%
CAGR 5-Years
-23%
CAGR 10-Years
-17%
W
WuXi XDC Cayman Inc
HKEX:2268
Capital Expenditures
-ÂĄ539.4m
CAGR 3-Years
-117%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Capital Expenditures?
Capital Expenditures
-218.7m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Capital Expenditures amounts to -218.7m CNY.

What is Joinn Laboratories China Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-9%

Over the last year, the Capital Expenditures growth was 17%. The average annual Capital Expenditures growth rates for Joinn Laboratories China Co Ltd have been -12% over the past three years , -9% over the past five years .

Back to Top